We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Pneumonia (main)
From WikEM
(Redirected from HCAP)
For pediatrics see pediatric pneumonia
Contents
Background
- Definition: infection of lung parenchyma
- Empirically classified based upon location/risk factors
Health care–associated pneumonia risk factors
- Hospitalized for 2 or more days within past 90 days
- Nursing home/long-term care residents
- Receiving home IV antibiotics
- Dialysis
- Receiving chronic wound care
- Receiving chemotherapy
- Immunocompromised
Pseudomonas risk factors
- Alcoholism
- Immunosuppression (including steroids)
- Structural lung disease
- Malnutrition
- Recent antibiotics
- Recent hospital stay
Causes of Pneumonia
Bacteria
Viral
- Common
- Influenza
- Respiratory syncytial virus
- Parainfluenza
- Rarer
- Adenovirus
- Metapneumovirus
- Severe acute respiratory syndrome (SARS)
- Middle east respiratory syndrome coronavirus (MERS)
- Cause other diseases, but sometimes cause pneumonia
Fungal
- Histoplasmosis
- Coccidioidomycosis
- Blastomycosis
- Pneumocystis jirovecii pneumonia (PCP)
- Sporotrichosis
- Cryptococcosis
- Aspergillosis
- Candidiasis
Parasitic
Commonly Encountered Pathogens by Risk Factor
Risk Factor | Associated Organism |
Alcoholism | |
COPD and/or Smoking | |
Nursing Home | |
Exposure to bird droppings | Histoplasma capsulatum |
Exposure to birds | Chlamydophila psittaci |
Exposure to rabbits | Francisella tularensis |
Exposure to farm animals | Coxiella burnetii (Q fever) |
Exposure to southwestern US | Coccidiomycosis (Valley fever) |
Early HIV | |
Late HIV (as above, plus:) | |
Aspiration | Anaerobes |
Structural Lung Disease (CF, bronchiectasis) | |
Injection drug use | |
Influenza |
|
Ventilator Associated Pneumonia |
Clinical Features
- Fever, chills, pleuritic chest pain, productive cough
- Fever is seen in 80%
- Tachypnea
- Most sensitive sign in elderly
- Abdominal pain, nausea and vomiting, diarrhea may be seen with Legionella infection
- Myalgia, fatigue
Differential Diagnosis
Shortness of breath
Emergent
- Pulmonary
- Airway obstruction
- Anaphylaxis
- Aspiration
- Asthma
- Cor pulmonale
- Inhalation exposure
- Noncardiogenic pulmonary edema
- Pneumonia
- Pneumocystis Pneumonia (PCP)
- Pulmonary embolism
- Pulmonary hypertension
- Tension pneumothorax
- Idiopathic pulmonary fibrosis acute exacerbation
- Cardiac
- Other Associated with Normal/↑ Respiratory Effort
- Other Associated with ↓ Respiratory Effort
Non-Emergent
- ALS
- Ascites
- Uncorrected ASD
- Congenital heart disease
- COPD exacerbation
- Fever
- Hyperventilation
- Neoplasm
- Obesity
- Panic attack
- Pleural effusion
- Polymyositis
- Porphyria
- Pregnancy
- Rib fracture
- Spontaneous pneumothorax
- Thyroid Disease
Evaluation
- CXR
- CBC
- Chemistry
If patient will be admitted:
- Blood Cultures are ONLY indicated for CAP patients with:
- ICU (required)
- Multi-lobar
- Pleural effusion
- Consider for higher-risk patients admitted with CAP
- Liver disease
- Immunocompromised
- Significant comorbidities
- Other risk factors
- Sputum staining
- If concern for particular organism
Chest X-Ray Mimics
- Malignancy
- Tuberculosis
- Pulmonary embolism - Hampton's hump
- Atelectasis
- ARDS
- Diffuse alveolar hemorrhage
- Multiple "cannonball" infiltrates
- Metastatic disease
- Septic emboli
- Right sided endocarditis
Management
Outpatient
Coverage targeted at S. pneumoniae, H. influenzae. M. pneumoniae, C. pneumoniae, and Legionella
Healthy
- Clarithromycin XL 1000mg PO QD x7d OR
- Azithromycin 500mg PO day 1, 250mg on days 2-5 OR
- Doxycycline 100mg BID x 10-14d (2nd line choice)
Unhealthy
Chronic heart, lung, liver, or renal disease; DM, alcholism, malignancy.
- Levofloxacin 750mg QD x5d OR
- Moxifloxacin 400mg QD x7-14d OR
- Amoxicillin/Clavulanate 2g BID AND
- Azithromycin 500mg day 1, 250mg days 2-5 OR
- Doxycycline 100mg PO BID x 7-10 days OR
- Clarithromycin 500mg PO BID x 7-10 days
Inpatient
- Monotherapy or combination therapy is acceptable. Combination therapy includes a cephalosporin and macrolide targeting atypicals and Strep Pneumonia [1]
- The use of adjunctive corticosteroids (methylprednisolone 0.5 mg/kg IV BID x 5d) in CAP of moderate-high severity (PSI Score IV or V; CURB-65 ≥ 2) is associated with:[2]
- ↓ mortality (3%)
- ↓ need for mechanical ventilation (5%)
- ↓ length of hospital stay (1d)
Community Acquired (Non-ICU)
Coverage against community acquired organisms plus M. catarrhalis, Klebsiella, S. aureus
- Levofloxacin 750mg IV/PO once daily OR
- Moxifloxacin 400mg IV/PO once daily OR
- Ceftriaxone 1g IV once daily PLUS
- Azithromycin 500mg IV/PO once daily OR
- Doxycycline 100mg IV/PO BID
Hospital Acquired or Ventilator Associated Pneumonia
- 3-drug regimen recommended options:
- Cefepime 1-2gm q8-12h OR ceftazidime 2gm q8h + Levofloxacin 750 mg PO/IV every 24 hours + Vancomycin 15mg/kg q12 OR
- Imipenem 500mg q6hr + cipro 400mg q8hr + vanco 15mg/kg q12 OR
- Piperacillin-Tazobactam 4.5gm q6h + cipro 400mg q8h + vanco 15mg/kg q12
- Consider tobramycin in place of fluoroquinolones given FDA 2016 warnings
Ventilator Associated Pneumnoia
- High Risk of MRSA: Use 3-Drug Regimen. Several options are available, but recommendation is to include an antibiotic from each of these categories:[3]
- 1. MRSA Antibiotic: Vancomycin 15mg/kg q12h OR Linezolid 600 mg IV q12h PLUS
- 2. Antipseudomonal Antibiotic: Piperacillin-Tazobactam 4.5gm q6h OR Cefepime 2 g IV q8h OR Imipenem 500 mg IV q6h OR Aztreonam 2 g IV q8h PLUS
- 3. GN Antibiotic With Antipseudomonal Activity: Cipro 400 mg IV q8h
ICU, low risk of pseudomonas
- Ceftriaxone 1gm IV and Azithromycin 500mg IV OR
- Ceftriaxone 1gm IV and (moxifloxacin 400mg IV or levofloxacin 750mg IV)
- Penicillin allergy
- (Moxifloxacin or levofloxacin) + (aztreonam 1-2gm IV or clindamycin 600mg IV)
ICU, risk of pseudomonas
- Cefipime, Imipenem, OR Piperacillin/Tazobactam + IV cipro/levo
- Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin
- Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo
References
- ↑ Chokshi R, Restrepo MI, Weeratunge N, Frei CR, Anzueto A, Mortensen EM. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. Jul 2007;26(7):447-51
- ↑ Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, Alexander PE, Fei Y, Vandvik PO, Loeb M, Guyatt GH. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med. Aug 11, 2015
- ↑ Kalil AC, Metersky ML, Klompas M et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016 Sep 1;63(5):e61-e111.
Disposition
Pneumonia severity index (Port Score)
Risk Factors |
Points |
Demographic Factors | |
Age for men |
Age |
Age for women |
Age -10 |
Nursing home resident |
+10 |
Coexisting Illnesses |
|
Neoplastic disease (active) |
+30 |
Chronic liver disease |
+20 |
Heart Failure |
+10 |
Cerebrovascular disease |
+10 |
Chronic renal disease |
+10 |
Physical Exam |
|
AMS |
+20 |
RR > 30/min |
+20 |
Sys BP < 90 |
+20 |
Temp <35 or >40 |
+15 |
Pulse > 125 |
+10 |
Lab and xray findings |
|
Arterial pH < 7.35 |
+30 |
BUN > 30 |
+20 |
Na <130 |
+20 |
Glucose > 250 |
+10 |
Hematocrit <30% |
+10 |
PaO2 < 60 or SpO2 < 90% |
+10 |
Pleural effusion |
+10 |
Classification
Class |
Points |
Mortality |
I |
<51 | 0.1% |
II |
51-70 | 0.6% |
III |
71-90 |
0.9% |
IV |
91-130 |
9.3% |
V |
>130 |
27% |
Disposition Pathway
- Classes I and II: consider discharge
- Class III: discharge verus admit based on clinical judgment
- Classes IV and V: consider admission
CURB-65
- Confusion
- bUn > 19 mg/dl
- RR > 30
- BP < 90 SBP, or < 60 DBP
- Age > 65
- Approximate 30-day mortalities and Tx considerations
- +1 --> 3%, outpt tx
- +2 -->7%, inpt, possible outpt
- +3 --> 14% inpt, possible ICU
- +4-5 --> 30% ICU